Prostate cancer trials in Sweden

In Sweden 38 Also abroad 1481

38 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Where
Goteborg, Solna, Uppsala
Age
18 years and over
People
1,310 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00
Phase 3Taking people
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Where
Stockholm
Age
18 years and over
People
900 worldwide
Run by
Pfizer
See details and how to joinNCT06629779 · EU 2024-511652-40-00
Phase 3Taking people
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Where
Malmo, Solna, Stockholm, Uppsala
Age
18 years and over
People
1,440 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00
Phase 1/2Taking people
Study to assess the safety and efficacy of the SpectraCure P18 System
Where
Malmo
Age
18 years and over
People
26 worldwide
Run by
SpectraCure AB (publ)
See details and how to join2022-502285-24-00 · EU 2022-502285-24-00
Phase 3Taking people
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Where
Solna, Uppsala
Age
18 years and over
People
1,314 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06136650 · EU 2023-504957-11-00
No phaseTaking people
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
Where
Many Locations
Age
18 years and over
People
1,600 worldwide
Run by
Bayer
See details and how to joinNCT07344779
Phase 3Taking people
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Where
Stockholm, Umeå
Age
18 years and over
People
670 worldwide
Run by
AstraZeneca
See details and how to joinNCT07611110
No phaseTaking people
The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer
Where
Uppsala
Age
18 years and over
People
1,400
Run by
Uppsala University
See details and how to joinNCT06446401
Phase 3Taking people
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Where
Goteborg, Malmo, Solna, Stockholm, Umea, Uppsala
Age
18 years and over
People
700 worldwide
Run by
AstraZeneca
See details and how to joinNCT06952803 · EU 2024-513586-39-00
Phase 1/2Taking people
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Where
Lund, Stockholm
Age
18 years to 130 years
People
695 worldwide
Run by
AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00
No phaseTaking people
Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
Where
Uppsala, Västerås
Age
18 years and over
People
210
Run by
Mälardalen University
See details and how to joinNCT06719206
Phase 3Taking people
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Where
Falun, Gothenburg, Helsingborg, Örebro, Östersund, Stockholm, Umeå, Uppsala
Age
75 years and over
People
980 worldwide
Run by
Sven Löffeler
See details and how to joinNCT05448547
Phase 2Not yet taking people in Sweden
A phase II, single arm two-phase, clinical study of individually adapted systemic radioligand therapy with 177Lu-PSMA I&T for patients with metastatic, castration-resistant prostate cancer
Where
Uppsala
Age
18 years and over
People
80
Run by
Region Uppsala
See details and how to join2026-527110-23-00 · EU 2026-527110-23-00
Phase 1Taking people
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
Where
Goteborg, Lund, Solna, Uppsala
Age
18 years and over
People
198 worldwide
Run by
Bayer
See details and how to joinNCT06217822 · EU 2023-507486-26-00
Phase 3Taking people
CYPENZA - A prospective cohort trial on antiandrogens influences on the pharmacokinetics of corticosteroids.
Where
Umea
Age
18 years and over
People
30
Run by
Region Vaesterbotten
See details and how to join2025-520571-66-00 · EU 2025-520571-66-00
Phase 4Taking people
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Where
Goteborg, Lund, Solna
Age
18 years to 100 years
People
700 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05803941 · EU 2023-503208-94-00
Phase 2Taking people
Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer
Where
Gothenburg, Lund
Age
18 years and over
People
168 worldwide
Run by
Curasight
See details and how to joinNCT06474806 · EU 2023-507111-35-00
Phase 2Taking people
Prostate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScore
Where
Goteborg, Solna
Age
18 years and over
People
100
Run by
Region Stockholm
See details and how to joinNCT07617272 · EU 2025-520639-17-00
No phaseTaking people
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Where
Malmö, Örebro, Umeå
Age
21 years and over
People
5,000 worldwide
Run by
Prostate Cancer Clinical Trials Consortium
See details and how to joinNCT03151629
Phase 1/2Taking people
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
Where
Malmö
Age
18 years and over
People
66 worldwide
Run by
SpectraCure AB
See details and how to joinNCT03067051
Phase 3Taking people
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
Where
Gothenburg, Malmö
Age
18 years and over
People
300 worldwide
Run by
UNICANCER
See details and how to joinNCT04916613 · EU 2022-502425-18-00
No phaseTaking people
AI-based Measurements of Tumour Burden in PSMA PET-CT
Where
Lund, Malmö
Age
20 years to 120 years
People
1,500
Run by
Elin Tragardh
See details and how to joinNCT06363435
No phaseTaking people
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
Where
Jönköping, Lund, Orebro, Stockholm, Umeå
Age
18 years and over
People
118
Run by
Karin Soderkvist
See details and how to joinNCT04983095
No phaseTaking people
Lymphedema After Urologic Surgery
Where
Gothenburg, Örebro
Age
18 years and over
People
400
Run by
Vastra Gotaland Region
See details and how to joinNCT05264337
No phaseTaking people
Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.
Where
Jönköping, Kalmar, Lund
Age
18 years and over
People
374
Run by
Lund University Hospital
See details and how to joinNCT04858880